Reliq Health Technologies Inc.
RQHTF
$0.0001
-$0.0099-99.00%
03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | |
---|---|---|---|---|---|
Revenue | 76.51% | 78.67% | 108.44% | 448.59% | 469.00% |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 76.51% | 78.67% | 108.44% | 448.59% | 469.00% |
Cost of Revenue | 63.99% | 159.75% | 178.91% | 2,753.60% | 249.27% |
Gross Profit | 83.23% | 50.19% | 81.12% | 149.81% | 759.55% |
SG&A Expenses | 37.59% | -55.95% | -61.81% | -25.46% | -50.70% |
Depreciation & Amortization | -0.47% | 2.35% | -0.47% | -66.75% | 251.67% |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 18.48% | -8.17% | -30.61% | 35.00% | 3.61% |
Operating Income | 176.65% | 101.59% | 83.42% | 43.30% | 72.37% |
Income Before Tax | 184.40% | 96.93% | 97.19% | 57.26% | 71.02% |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | 184.40% | 96.93% | 97.19% | 57.26% | 71.02% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | 184.40% | 96.93% | 97.19% | 57.26% | 71.02% |
EBIT | 176.65% | 101.59% | 83.42% | 43.30% | 72.37% |
EBITDA | 183.18% | 101.61% | 83.95% | 42.61% | 73.17% |
EPS Basic | 188.24% | 96.81% | 97.35% | 55.88% | 74.81% |
Normalized Basic EPS | 185.71% | 96.55% | 97.46% | 56.25% | 75.29% |
EPS Diluted | 188.24% | 96.81% | 97.35% | 55.88% | 74.81% |
Normalized Diluted EPS | 185.71% | 96.55% | 97.46% | 56.25% | 75.29% |
Average Basic Shares Outstanding | -1.90% | 7.11% | 7.20% | -1.77% | 14.05% |
Average Diluted Shares Outstanding | -1.90% | 7.11% | 7.20% | -1.77% | 14.05% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |